COMPANY
Celea Therapeutics
Since the raise (Jul 2, 2026): 8 of 8 open jobs were first seen after it.
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Clinical Scientist, Director | Boston | Oct 9, 2026 | Oct 10, 2026 |
| Director, Head of Corporate Communications | Boston | Oct 7, 2026 | Oct 8, 2026 |
| IT Systems Manager, AI Administration | Boston | Oct 7, 2026 | Oct 8, 2026 |
| Senior Paralegal, Corporate & Securities | Boston | Oct 1, 2026 | Oct 8, 2026 |
| Executive Assistant | Boston | Oct 1, 2026 | Oct 8, 2026 |
Raises and deals from press releases
- Raise Undisclosed round · $180M · announced Jul 2, 2026 Company release ↗
Source quote
- Jul 2, 2026 · Company release ↗
“Celea Therapeutics Announces $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF)”
- Jul 2, 2026 · Company release ↗
Timeline
Open jobs 8
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Clinical Scientist, Director | Boston | Oct 9, 2026 | Oct 10, 2026 | Senior |
| Director, Head of Corporate Communications | Boston | Oct 7, 2026 | Oct 8, 2026 | Executive |
| IT Systems Manager, AI Administration | Boston | Oct 7, 2026 | Oct 8, 2026 | Mid |
| Senior Paralegal, Corporate & Securities | Boston | Oct 1, 2026 | Oct 8, 2026 | Senior |
| Executive Assistant | Boston | Oct 1, 2026 | Oct 8, 2026 | Mid |
| Associate Director, Medical Writing | Boston | Sep 1, 2026 | Oct 8, 2026 | Senior |
| Vice President, Regulatory Affairs | Boston | Aug 19, 2026 | Oct 8, 2026 | Executive |
| Join Our Talent Network | Boston, MA | Aug 6, 2026 | Oct 8, 2026 | Not stated |
Funding
- Private equity round: $180M (total, as published), announced Jul 2, 2026. Source: company's own press page. source ↗
Connect
See your connections at Celea Therapeutics on LinkedIn (search by name, results not checked)